Keeping the US reciprocal tariffs and its future impact on Indian businesses in mind, Union Commerce and Industry Minister, ...
That's why Veeva Systems should remain a leader in its niche and deliver excellent returns over the long run. It's a top stock to buy and hold for the next two decades.
5h
Louisville Public Media on MSNDrugmakers bleed horseshoe crab for tests. Some push for a sustainable alternativeIndianapolis Zoo and Eli Lilly are part of a push to move medical industry away from using horseshoe crab blood and towards synthetic genetically engineered alternatives.
This is CNBC’s coverage of how U.S. trade partners, industries and employers respond to President Donald Trump’s historic ...
Medicare delays decision on obesity drug coverage, impacting millions of seniors and big weight-loss drugmakers like Eli ...
Extending coverage for the medications through Medicare could cost $35 billion over nine years, a congressional analysis ...
Trump's 10% global tariff spares pharmaceuticals but impacts medical devices, with diabetes device makers facing the greatest ...
Citing "objectionable conditions," the agency said there were problems with the way Raptim Research tested medicines in India ...
President Trump spared pharmaceuticals from the opening salvo in his campaign to transform the economy through “reciprocal” ...
This week's import-tax rules, announced by President Trump, exempt pharmaceuticals, but more rules are in the pipeline.
Massive cuts at the FDA have hit staff tied to drug reviews and user fees, putting future approvals in jeopardy, according to ...
But at the same time, industry leaders are bracing for the news that they think is inevitable given Trump’s declaration in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results